Showing 1 - 8 results of 8 for search 'Meletios Athanasios Dimopoulos', query time: 0.02s Refine Results
  1. 1
    Observation or treatment for smoldering multiple myeloma? A systematic review and meta-analysis of randomized controlled studies

    Observation or treatment for smoldering multiple myeloma? A systematic review and meta-analysis of randomized controlled studies by Ioannis Ntanasis-Stathopoulos, Charalampos Filippatos, Panagiotis Malandrakis, Efstathios Kastritis, Evangelos Terpos, Meletios-Athanasios Dimopoulos, Maria Gavriatopoulou

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Molecular Prognostic Factors in Uterine Serous Carcinomas: A Systematic Review

    Molecular Prognostic Factors in Uterine Serous Carcinomas: A Systematic Review by Anna Svarna, Michalis Liontos, Alkistis Papatheodoridi, Aristea-Maria Papanota, Eleni Zografos, Maria Kaparelou, Flora Zagouri, Meletios-Athanasios Dimopoulos

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting

    Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting by Efthymia Skafida, Angeliki Andrikopoulou, Evangelos Terpos, Christos Markellos, Savvina Moustafa, Dimitrios Pectasides, Meletios-Athanasios Dimopoulos, Flora Zagouri, Dimitrios Vassilopoulos

    Published 2023-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Correction: The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development

    Correction: The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development by Pralay Mukhopadhyay, Hesham A. Abdullah, Joanna B. Opalinska, Prani Paka, Eric Richards, Katja Weisel, Suzanne Trudel, Maria-Victoria Mateos, Meletios Athanasios Dimopoulos, Sagar Lonial

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development

    The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development by Pralay Mukhopadhyay, Hesham A. Abdullah, Joanna B. Opalinska, Prani Paka, Eric Richards, Katja Weisel, Suzanne Trudel, Maria-Victoria Mateos, Meletios Athanasios Dimopoulos, Sagar Lonial

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome

    Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome by Konstantinos Soureas, Panagiotis Malandrakis, Maria-Alexandra Papadimitriou, Christos Minopoulos, Ioannis Ntanasis-Stathopoulos, Christine-Ivy Liacos, Maria Gavriatopoulou, Efstathios Kastritis, Meletios-Athanasios Dimopoulos, Andreas Scorilas, Margaritis Avgeris, Evangelos Terpos

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Isatuximab plus bortezomib, lenalidomide, and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma patients: a frailty subgroup analysis of the IMROZ trial

    Isatuximab plus bortezomib, lenalidomide, and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma patients: a frailty subgroup analysis of the IMROZ trial by Salomon Manier, Meletios-Athanasios Dimopoulos, Xavier P. Leleu, Philippe Moreau, Michele Cavo, Hartmut Goldschmidt, Robert Z. Orlowski, Muriel Tron, Christina Tekle, Marie-France Brégeault, Andrea T. Shafer, Meral Beksac, Thierry Facon

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    The Role of the Bone Marrow Microenvironment in Physical Function and Quality of Life in Patients with Multiple Myeloma After First-Line Treatment with Novel Agents and Autologous Transplantation

    The Role of the Bone Marrow Microenvironment in Physical Function and Quality of Life in Patients with Multiple Myeloma After First-Line Treatment with Novel Agents and Autologous... by Polyxeni Spiliopoulou, Pantelis Rousakis, Chrysanthi Panteli, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou, Nikolaos Kanellias, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Foteini Theodorakakou, Despina Fotiou, Evangelos Terpos, Vassilios Myrianthopoulos, Maria Gavriatopoulou, Ourania E. Tsitsilonis, Efstathios Kastritis, Meletios Athanasios Dimopoulos, Gerasimos Terzis

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: